Stocks of biopharmaceutical companies making diabetes drugs haven't been huge winners in 2018 so far. But it's a much different story for medical device companies that focus on monitoring and treating diabetes. Several of these stocks soared in the first half of the year.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,